IBDEI03V ; ; 09-FEB-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,4706,1,4,0)
 ;;=4^C82.25
 ;;^UTILITY(U,$J,358.3,4706,2)
 ;;=^5001486
 ;;^UTILITY(U,$J,358.3,4707,0)
 ;;=C82.26^^22^216^165
 ;;^UTILITY(U,$J,358.3,4707,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4707,1,3,0)
 ;;=3^Follicular Lymphoma Grade III,Intrapelvic Nodes
 ;;^UTILITY(U,$J,358.3,4707,1,4,0)
 ;;=4^C82.26
 ;;^UTILITY(U,$J,358.3,4707,2)
 ;;=^5001487
 ;;^UTILITY(U,$J,358.3,4708,0)
 ;;=C82.27^^22^216^168
 ;;^UTILITY(U,$J,358.3,4708,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4708,1,3,0)
 ;;=3^Follicular Lymphoma Grade III,Spleen
 ;;^UTILITY(U,$J,358.3,4708,1,4,0)
 ;;=4^C82.27
 ;;^UTILITY(U,$J,358.3,4708,2)
 ;;=^5001488
 ;;^UTILITY(U,$J,358.3,4709,0)
 ;;=C82.28^^22^216^167
 ;;^UTILITY(U,$J,358.3,4709,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4709,1,3,0)
 ;;=3^Follicular Lymphoma Grade III,Mult Site Nodes
 ;;^UTILITY(U,$J,358.3,4709,1,4,0)
 ;;=4^C82.28
 ;;^UTILITY(U,$J,358.3,4709,2)
 ;;=^5001489
 ;;^UTILITY(U,$J,358.3,4710,0)
 ;;=C82.29^^22^216^161
 ;;^UTILITY(U,$J,358.3,4710,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4710,1,3,0)
 ;;=3^Follicular Lymphoma Grade III,Extranodal/Solid Organ Sites
 ;;^UTILITY(U,$J,358.3,4710,1,4,0)
 ;;=4^C82.29
 ;;^UTILITY(U,$J,358.3,4710,2)
 ;;=^5001490
 ;;^UTILITY(U,$J,358.3,4711,0)
 ;;=C82.30^^22^216^179
 ;;^UTILITY(U,$J,358.3,4711,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4711,1,3,0)
 ;;=3^Follicular Lymphoma Grade IIIa,Unspec Site
 ;;^UTILITY(U,$J,358.3,4711,1,4,0)
 ;;=4^C82.30
 ;;^UTILITY(U,$J,358.3,4711,2)
 ;;=^5001491
 ;;^UTILITY(U,$J,358.3,4712,0)
 ;;=C82.31^^22^216^172
 ;;^UTILITY(U,$J,358.3,4712,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4712,1,3,0)
 ;;=3^Follicular Lymphoma Grade IIIa,Head/Face/Neck Nodes
 ;;^UTILITY(U,$J,358.3,4712,1,4,0)
 ;;=4^C82.31
 ;;^UTILITY(U,$J,358.3,4712,2)
 ;;=^5001492
 ;;^UTILITY(U,$J,358.3,4713,0)
 ;;=C82.32^^22^216^176
 ;;^UTILITY(U,$J,358.3,4713,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4713,1,3,0)
 ;;=3^Follicular Lymphoma Grade IIIa,Intrathoracic Nodes
 ;;^UTILITY(U,$J,358.3,4713,1,4,0)
 ;;=4^C82.32
 ;;^UTILITY(U,$J,358.3,4713,2)
 ;;=^5001493
 ;;^UTILITY(U,$J,358.3,4714,0)
 ;;=C82.33^^22^216^174
 ;;^UTILITY(U,$J,358.3,4714,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4714,1,3,0)
 ;;=3^Follicular Lymphoma Grade IIIa,Intra-Abdominal Nodes
 ;;^UTILITY(U,$J,358.3,4714,1,4,0)
 ;;=4^C82.33
 ;;^UTILITY(U,$J,358.3,4714,2)
 ;;=^5001494
 ;;^UTILITY(U,$J,358.3,4715,0)
 ;;=C82.34^^22^216^170
 ;;^UTILITY(U,$J,358.3,4715,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4715,1,3,0)
 ;;=3^Follicular Lymphoma Grade IIIa,Axilla/Upper Limb Nodes
 ;;^UTILITY(U,$J,358.3,4715,1,4,0)
 ;;=4^C82.34
 ;;^UTILITY(U,$J,358.3,4715,2)
 ;;=^5001495
 ;;^UTILITY(U,$J,358.3,4716,0)
 ;;=C82.35^^22^216^173
 ;;^UTILITY(U,$J,358.3,4716,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4716,1,3,0)
 ;;=3^Follicular Lymphoma Grade IIIa,Ing Region/Lower Limb Nodes
 ;;^UTILITY(U,$J,358.3,4716,1,4,0)
 ;;=4^C82.35
 ;;^UTILITY(U,$J,358.3,4716,2)
 ;;=^5001496
 ;;^UTILITY(U,$J,358.3,4717,0)
 ;;=C82.36^^22^216^175
 ;;^UTILITY(U,$J,358.3,4717,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4717,1,3,0)
 ;;=3^Follicular Lymphoma Grade IIIa,Intrapelvic Nodes
 ;;^UTILITY(U,$J,358.3,4717,1,4,0)
 ;;=4^C82.36
 ;;^UTILITY(U,$J,358.3,4717,2)
 ;;=^5001497
 ;;^UTILITY(U,$J,358.3,4718,0)
 ;;=C82.37^^22^216^178
 ;;^UTILITY(U,$J,358.3,4718,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4718,1,3,0)
 ;;=3^Follicular Lymphoma Grade IIIa,Spleen
 ;;^UTILITY(U,$J,358.3,4718,1,4,0)
 ;;=4^C82.37
 ;;^UTILITY(U,$J,358.3,4718,2)
 ;;=^5001498
 ;;^UTILITY(U,$J,358.3,4719,0)
 ;;=C82.38^^22^216^177
 ;;^UTILITY(U,$J,358.3,4719,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4719,1,3,0)
 ;;=3^Follicular Lymphoma Grade IIIa,Mult Site Nodes
 ;;^UTILITY(U,$J,358.3,4719,1,4,0)
 ;;=4^C82.38
 ;;^UTILITY(U,$J,358.3,4719,2)
 ;;=^5001499
 ;;^UTILITY(U,$J,358.3,4720,0)
 ;;=C82.39^^22^216^171
 ;;^UTILITY(U,$J,358.3,4720,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4720,1,3,0)
 ;;=3^Follicular Lymphoma Grade IIIa,Extranodal/Solid Organ Sites
 ;;^UTILITY(U,$J,358.3,4720,1,4,0)
 ;;=4^C82.39
 ;;^UTILITY(U,$J,358.3,4720,2)
 ;;=^5001500
 ;;^UTILITY(U,$J,358.3,4721,0)
 ;;=C82.40^^22^216^189
 ;;^UTILITY(U,$J,358.3,4721,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4721,1,3,0)
 ;;=3^Follicular Lymphoma Grade IIIb,Unspec Site
 ;;^UTILITY(U,$J,358.3,4721,1,4,0)
 ;;=4^C82.40
 ;;^UTILITY(U,$J,358.3,4721,2)
 ;;=^5001501
 ;;^UTILITY(U,$J,358.3,4722,0)
 ;;=C82.41^^22^216^182
 ;;^UTILITY(U,$J,358.3,4722,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4722,1,3,0)
 ;;=3^Follicular Lymphoma Grade IIIb,Head/Face/Neck Nodes
 ;;^UTILITY(U,$J,358.3,4722,1,4,0)
 ;;=4^C82.41
 ;;^UTILITY(U,$J,358.3,4722,2)
 ;;=^5001502
 ;;^UTILITY(U,$J,358.3,4723,0)
 ;;=C82.42^^22^216^186
 ;;^UTILITY(U,$J,358.3,4723,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4723,1,3,0)
 ;;=3^Follicular Lymphoma Grade IIIb,Intrathoracic Nodes
 ;;^UTILITY(U,$J,358.3,4723,1,4,0)
 ;;=4^C82.42
 ;;^UTILITY(U,$J,358.3,4723,2)
 ;;=^5001503
 ;;^UTILITY(U,$J,358.3,4724,0)
 ;;=C82.43^^22^216^184
 ;;^UTILITY(U,$J,358.3,4724,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4724,1,3,0)
 ;;=3^Follicular Lymphoma Grade IIIb,Intra-Abdominal Nodes
 ;;^UTILITY(U,$J,358.3,4724,1,4,0)
 ;;=4^C82.43
 ;;^UTILITY(U,$J,358.3,4724,2)
 ;;=^5001504
 ;;^UTILITY(U,$J,358.3,4725,0)
 ;;=C82.44^^22^216^180
 ;;^UTILITY(U,$J,358.3,4725,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4725,1,3,0)
 ;;=3^Follicular Lymphoma Grade IIIb,Axilla/Upper Limb Nodes
 ;;^UTILITY(U,$J,358.3,4725,1,4,0)
 ;;=4^C82.44
 ;;^UTILITY(U,$J,358.3,4725,2)
 ;;=^5001505
 ;;^UTILITY(U,$J,358.3,4726,0)
 ;;=C82.45^^22^216^183
 ;;^UTILITY(U,$J,358.3,4726,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4726,1,3,0)
 ;;=3^Follicular Lymphoma Grade IIIb,Ing Region/Lower Limb Nodes
 ;;^UTILITY(U,$J,358.3,4726,1,4,0)
 ;;=4^C82.45
 ;;^UTILITY(U,$J,358.3,4726,2)
 ;;=^5001506
 ;;^UTILITY(U,$J,358.3,4727,0)
 ;;=C82.46^^22^216^185
 ;;^UTILITY(U,$J,358.3,4727,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4727,1,3,0)
 ;;=3^Follicular Lymphoma Grade IIIb,Intrapelvic Nodes
 ;;^UTILITY(U,$J,358.3,4727,1,4,0)
 ;;=4^C82.46
 ;;^UTILITY(U,$J,358.3,4727,2)
 ;;=^5001507
 ;;^UTILITY(U,$J,358.3,4728,0)
 ;;=C82.47^^22^216^188
 ;;^UTILITY(U,$J,358.3,4728,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4728,1,3,0)
 ;;=3^Follicular Lymphoma Grade IIIb,Spleen
 ;;^UTILITY(U,$J,358.3,4728,1,4,0)
 ;;=4^C82.47
 ;;^UTILITY(U,$J,358.3,4728,2)
 ;;=^5001508
 ;;^UTILITY(U,$J,358.3,4729,0)
 ;;=C82.48^^22^216^187
 ;;^UTILITY(U,$J,358.3,4729,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4729,1,3,0)
 ;;=3^Follicular Lymphoma Grade IIIb,Mult Site Nodes
 ;;^UTILITY(U,$J,358.3,4729,1,4,0)
 ;;=4^C82.48
 ;;^UTILITY(U,$J,358.3,4729,2)
 ;;=^5001509
 ;;^UTILITY(U,$J,358.3,4730,0)
 ;;=C82.49^^22^216^181
 ;;^UTILITY(U,$J,358.3,4730,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4730,1,3,0)
 ;;=3^Follicular Lymphoma Grade IIIb,Extranodal/Solid Organ Sites
 ;;^UTILITY(U,$J,358.3,4730,1,4,0)
 ;;=4^C82.49
 ;;^UTILITY(U,$J,358.3,4730,2)
 ;;=^5001510
 ;;^UTILITY(U,$J,358.3,4731,0)
 ;;=C82.50^^22^216^123
 ;;^UTILITY(U,$J,358.3,4731,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4731,1,3,0)
 ;;=3^Diffuse Follicle Center Lymphoma,Unspec Site
 ;;^UTILITY(U,$J,358.3,4731,1,4,0)
 ;;=4^C82.50
 ;;^UTILITY(U,$J,358.3,4731,2)
 ;;=^5001511
 ;;^UTILITY(U,$J,358.3,4732,0)
 ;;=C82.51^^22^216^116
 ;;^UTILITY(U,$J,358.3,4732,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4732,1,3,0)
 ;;=3^Diffuse Follicle Center Lymphoma,Head/Face/Neck Nodes
 ;;^UTILITY(U,$J,358.3,4732,1,4,0)
 ;;=4^C82.51
 ;;^UTILITY(U,$J,358.3,4732,2)
 ;;=^5001512
 ;;^UTILITY(U,$J,358.3,4733,0)
 ;;=C82.52^^22^216^120
 ;;^UTILITY(U,$J,358.3,4733,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4733,1,3,0)
 ;;=3^Diffuse Follicle Center Lymphoma,Intrathoracic Nodes
 ;;^UTILITY(U,$J,358.3,4733,1,4,0)
 ;;=4^C82.52
 ;;^UTILITY(U,$J,358.3,4733,2)
 ;;=^5001513
 ;;^UTILITY(U,$J,358.3,4734,0)
 ;;=C82.53^^22^216^118
 ;;^UTILITY(U,$J,358.3,4734,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4734,1,3,0)
 ;;=3^Diffuse Follicle Center Lymphoma,Intra-Abdominal Nodes
 ;;^UTILITY(U,$J,358.3,4734,1,4,0)
 ;;=4^C82.53
 ;;^UTILITY(U,$J,358.3,4734,2)
 ;;=^5001514
 ;;^UTILITY(U,$J,358.3,4735,0)
 ;;=C82.54^^22^216^114
 ;;^UTILITY(U,$J,358.3,4735,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4735,1,3,0)
 ;;=3^Diffuse Follicle Center Lymphoma,Axilla/Upper Limb Nodes
 ;;^UTILITY(U,$J,358.3,4735,1,4,0)
 ;;=4^C82.54
 ;;^UTILITY(U,$J,358.3,4735,2)
 ;;=^5001515
 ;;^UTILITY(U,$J,358.3,4736,0)
 ;;=C82.55^^22^216^117
 ;;^UTILITY(U,$J,358.3,4736,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4736,1,3,0)
 ;;=3^Diffuse Follicle Center Lymphoma,Ing Region/Lower Limb Nodes
 ;;^UTILITY(U,$J,358.3,4736,1,4,0)
 ;;=4^C82.55
 ;;^UTILITY(U,$J,358.3,4736,2)
 ;;=^5001516
 ;;^UTILITY(U,$J,358.3,4737,0)
 ;;=C82.56^^22^216^119
 ;;^UTILITY(U,$J,358.3,4737,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4737,1,3,0)
 ;;=3^Diffuse Follicle Center Lymphoma,Intrapelvic Nodes
 ;;^UTILITY(U,$J,358.3,4737,1,4,0)
 ;;=4^C82.56
 ;;^UTILITY(U,$J,358.3,4737,2)
 ;;=^5001517
 ;;^UTILITY(U,$J,358.3,4738,0)
 ;;=C82.57^^22^216^122
 ;;^UTILITY(U,$J,358.3,4738,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4738,1,3,0)
 ;;=3^Diffuse Follicle Center Lymphoma,Spleen
 ;;^UTILITY(U,$J,358.3,4738,1,4,0)
 ;;=4^C82.57
 ;;^UTILITY(U,$J,358.3,4738,2)
 ;;=^5001518
 ;;^UTILITY(U,$J,358.3,4739,0)
 ;;=C82.58^^22^216^121
 ;;^UTILITY(U,$J,358.3,4739,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4739,1,3,0)
 ;;=3^Diffuse Follicle Center Lymphoma,Mult Site Nodes
 ;;^UTILITY(U,$J,358.3,4739,1,4,0)
 ;;=4^C82.58
 ;;^UTILITY(U,$J,358.3,4739,2)
 ;;=^5001519
 ;;^UTILITY(U,$J,358.3,4740,0)
 ;;=C82.59^^22^216^115
 ;;^UTILITY(U,$J,358.3,4740,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4740,1,3,0)
 ;;=3^Diffuse Follicle Center Lymphoma,Extranodal/Solid Organ Sites
